BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24790045)

  • 1. [The development of mucosal vaccine using bacterial function for targeting mucosal tissues].
    Suzuki H; Kondoh M; Yagi K; Kiyono H; Kunisawa J
    Yakugaku Zasshi; 2014; 134(5):629-34. PubMed ID: 24790045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine].
    Kunisawa J; Gohda M; Kiyono H
    Yakugaku Zasshi; 2007 Feb; 127(2):319-26. PubMed ID: 17268152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucosal immunity and vaccine development].
    Anjuère F; Czerkinsky C
    Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
    Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
    Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers: a versatile approach for mucosal vaccine delivery.
    Mody N; Sharma R; Agrawal U; Vyas SP
    Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal vaccine design and delivery.
    Woodrow KA; Bennett KM; Lo DD
    Annu Rev Biomed Eng; 2012; 14():17-46. PubMed ID: 22524387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
    Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
    Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal delivery of vaccines in domestic animals.
    Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA
    Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunity and strategies for novel microbial vaccines.
    Mestecky J; Moldoveanu Z; Novak M; Compans RW
    Acta Paediatr Jpn; 1994 Oct; 36(5):537-44. PubMed ID: 7825460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
    Boyaka PN
    J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New advances in mucosal vaccination.
    Ranasinghe C
    Immunol Lett; 2014 Oct; 161(2):204-6. PubMed ID: 24462961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
    Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
    Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
    Wang SH; Thompson AL; Hickey AJ; Staats HF
    Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal vaccination--an old but still vital strategy.
    Długońska H; Grzybowski M
    Ann Parasitol; 2012; 58(1):1-8. PubMed ID: 23094329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for systemic and mucosal vaccine delivery.
    Shahiwala A; Vyas TK; Amiji MM
    Recent Pat Drug Deliv Formul; 2007; 1(1):1-9. PubMed ID: 19075870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers.
    Garg NK; Mangal S; Khambete H; Tyagi RK
    Recent Pat Drug Deliv Formul; 2010 Jun; 4(2):114-28. PubMed ID: 20380624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.